Skip to main content

Day: July 28, 2025

Qualigen Therapeutics Provides Update on Nasdaq Communications and Continued Listing Status

CARLSBAD, Calif., July 28, 2025 (GLOBE NEWSWIRE) — Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) received two different communications from the staff of the Nasdaq Listing Qualifications office of the Nasdaq Stock Market, LLC. The Company received the first notice from the Nasdaq Listings Qualifications office of the Nasdaq Stock Market LLC on July 23, 2025, informing the Company that as reflected in the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 filed with the SEC on July 21, 2025, the Company failed to comply with the $2.5 million stockholder’s equity required under Nasdaq Rule 5550(b)(1) (the “Equity Rule”) or any alternative standard under Nasdaq 5550(b). On June 24, 2025, the Company received a second communication from the Office of the General Counsel of Nasdaq, confirming that...

Continue reading

Maravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025

SAN DIEGO, July 28, 2025 (GLOBE NEWSWIRE) — Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter 2025 financial and operating results after the market close on Monday, August 11, 2025, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET. To participate in the conference call by telephone, dial (800) 267-6316 or (203) 518-9783 and reference Maravai LifeSciences, Conference ID MARAVAI. The call will also be available via live or archived webcast on the “Investors” section of the Maravai web site at https://investors.maravai.com. About Maravai Maravai is a leading life sciences company providing critical products to enable the development of drug therapies,...

Continue reading

Early Warrant Expiration: Preliminary Notice

Price of Enovix common stock has exceeded $10.50 for five trading days The earliest expiration date for the Warrants is August 19, 2025 Reserves right to set Alternate Expiration Date for Warrants  FREMONT, Calif., July 28, 2025 (GLOBE NEWSWIRE) — Enovix Corporation (Nasdaq: ENVX, ENVXW) (“Company” or “Enovix”), a leader in advanced silicon battery technology, today announced that the price of its common stock has exceeded $10.50 for five trading days since the distribution of the warrants to purchase common stock (the “Warrants”), currently traded on Nasdaq under ENVXW. Today’s closing price for Enovix common stock was $15.06 per share, and the Warrants are currently in-the-money based on their $8.75 per share exercise price. The earliest expiration date for the Warrants is August 19, 2025, subject to Enovix common stock continuing...

Continue reading

Farmers & Merchants Bancorp, Inc. Reports 2025 Second-Quarter and Year-to-Date Financial Results

ARCHBOLD, Ohio, July 28, 2025 (GLOBE NEWSWIRE) — Farmers & Merchants Bancorp, Inc. (Nasdaq: FMAO) today reported financial results for the 2025 second quarter and year-to-date ended June 30, 2025. 2025 Second Quarter Financial and Operating Highlights(at June 30, 2025 and on a year-over-year basis unless noted)89 consecutive quarters of profitability Net income increased 35.7% to $7.7 million, or $0.56 per basic and diluted share Net interest margin expands for fourth consecutive quarter, up 51 basis points year-over-year to 3.22% Total loans increased by $67.2 million, or 2.6% to $2.63 billion Total assets increased by $23.1 million, or 0.7% to $3.35 billion Total deposits increased by $69.2 million, or 2.6% to $2.71 billion Efficiency ratio improved to 64.93%, compared to 69.03% Asset quality remains at historically strong...

Continue reading

Tilray Brands Reports Fourth Quarter and Fiscal 2025 Financial Results

Fiscal Year Net Revenue of $821 Million, $834 Million in Constant Currency, Strategic Decisions Impacted Revenue by $35 Million Q4 Consolidated Adjusted EBITDA is the 2nd Highest in the Company’s History International Cannabis Revenue Increased 71% in Q4 and 19% for the Fiscal Year; Canadian Cannabis Remained #1 by Revenue in the Fiscal Year; Global Cannabis Gross Margin Increased by ~700 Basis Points in the Fiscal Year 19% Revenue Growth in Tilray Beverages with $241 Million for the Fiscal Year 9% Revenue Growth in Tilray Wellness with $60 Million for the Fiscal Year Strong Balance Sheet with $256 Million Available in Cash and Marketable Securities; Total Debt Repayments of ~$100 Million to Date Fiscal Year 2026 Adjusted EBITDA Expected to be Between $62 Million – $72 Million NEW YORK and LONDON and LEAMINGTON, Ontario, July 28,...

Continue reading

Universal Safety Products, Inc. (formerly Universal Security Instruments, Inc.) Announces its Fourth-Quarter and Year-End Results

OWINGS MILLS, Md., July 28, 2025 (GLOBE NEWSWIRE) — Universal Safety Products, Inc. (formerly Universal Security Instruments, Inc.) (NYSE American LLC: UUU) today announced its financial results for the fourth quarter and its fiscal year ended March 31, 2025. The Company reported:For the fourth quarter ended March 31, 2025, sales increased $1,780,152 (40.0%) to $6,226,621 from $4,446,469 from the comparable period last year. The Company reported net income of $1,302,551, or $0.56 per basic and diluted share compared to a net loss of $776,671, or $0.34 per basic and diluted share for the comparable period of the previous year. For the twelve months ended March 31, 2025, sales increased $4,045,881 (20.7%) to $23,563,554 versus $19,517,673 for the fiscal year ended March 31, 2024. The Company reported net income of $500,684, or...

Continue reading

RCLCO Mid-Year Report Ranks Summerlin® and Bridgeland® Among Nation’s Top-Selling Master Planned Communities

Howard Hughes Communities Sustain Strong Momentum in Home Sales Across National PortfolioSummerlinSummerlin, a Howard Hughes community in Las VegasBridgelandBridgeland, a Howard Hughes community in the Greater Houston AreaTHE WOODLANDS, Texas, July 28, 2025 (GLOBE NEWSWIRE) — Summerlin® and Bridgeland®, two of the award-winning communities in the Howard Hughes Holdings (NYSE: HHH) portfolio, have been ranked among the country’s top-selling master planned communities (MPCs), according to the mid-year 2025 report released by national real estate consultant RCLCO. The Summerlin community in Las Vegas ranked #7 on the RCLCO list with 515 new homes sold during the first half of 2025, and Bridgeland, in the Greater Houston area, ranked #14 nationwide with 438 new homes sold by mid-year. “The impressive mid-year...

Continue reading

Azerion Announces Additional Share Purchases by Leadership Team Members

Amsterdam, 28 July 2025 – Azerion announces that it has been informed that several members of its Executive Committee along with other members of the operational leadership team have mandated or will mandate Arctic Securities to acquire shares in the company on their behalf. This decision highlights their strong belief in the company’s strategic vision and its potential for future growth. Arctic Securities may, at its own discretion in the period between 29 July 2025 and 30 September 2025, purchase Azerion shares on behalf of the relevant Executive Committee and leadership team members up to a collective value of up to €1.5 million and transfer them to each member’s securities account. Under the arrangement, Arctic Securities may acquire up to approximately 1.3 million Azerion shares, based on the closing price on Euronext...

Continue reading

Correction: iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering

WOBURN, Mass., July 28, 2025 (GLOBE NEWSWIRE) — This press release corrects a version issued on July 25, 2025 that incorrectly listed KCSA Strategic Communications as iSpecimen’s investor relations contact. KCSA is not currently affiliated with iSpecimen Inc. and was mistakenly included in the prior release. The corrected release is below in its entirety. iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced on July 25, 2025 the closing of its previously announced underwritten public offering of 5,714,283 shares of its common stock (or pre-funded warrants to purchase common stock in lieu thereof) at a public offering price of $0.70 per share (the “Offering”). The aggregate...

Continue reading

Atico Mining Announces Closing of the Fully Subscribed $3.2M LIFE Offering, Raising $6.5M Combined with the Rights Offering

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, July 28, 2025 (GLOBE NEWSWIRE) — Atico Mining Corporation (the “Company” or “Atico”) (TSX.V: ATY | OTC: ATCMF) is pleased to announce the closing of its offering under the listed issuer financing exemption (the “LIFE Offering”), previously disclosed in the Company’s press releases dated June 9, 2025, June 13, 2025 and July 22, 2025. Under the LIFE Offering, Atico sold 29,090,910 units of the Company (the “LIFE Units”), at a subscription price of $0.11 per LIFE Unit, for gross proceeds of $3,200,000. Under the LIFE Offering and the Company’s rights offering that closed on July 22, 2025 (the “Rights Offering”, and together with the LIFE Offering, the “Offerings”), the Company raised aggregate gross...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.